Compare Boston Scientific Corporation (BSX) vs Energy Select Sector SPDR Fund (XLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs Energy Select Sector SPDR Fund — how do they compare? Boston Scientific Corporation trades at $51.26 (market cap $74.19B), while Energy Select Sector SPDR Fund trades at $60.73. The key difference: Energy Select Sector SPDR Fund is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | XLE | |
|---|---|---|
Market Cap | $74.19B | — |
Sector | Health | — |
52-Week High | $108.14 | $62.57 |
52-Week Low | $42.63 | $42.33 |
Enterprise Value | $86.27B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BSX trades at $50.46, up 2.33% today, with strong earnings beats in recent quarters and a bullish technical trend. Revenue grew to $20.07B in 2025, with net income margin expanding to 17.5%. The stock shows robust institutional support and insider buying, while facing near-term headwinds from competitive pressures in key segments like WATCHMAN.
Outlook remains positive with 86% analyst buy ratings and a $67.21 consensus price target, implying 33% upside. Risks include guidance cuts and market share losses, but solid cash flow and valuation metrics support long-term growth potential for patient investors.
XLE trades at $60.47, up 0.47% with a bullish technical signal from moving averages. The ETF has rallied 40.52% over the past year, driven by strong oil prices and geopolitical tensions in the Middle East. Recent earnings from major holdings like ExxonMobil and Chevron showed profit surges, supporting the sector's momentum. Technical indicators show support at $59 and resistance at $61, with RSI readings in neutral territory suggesting room for further movement.
Outlook remains positive but faces geopolitical risks. The energy sector benefits from elevated oil prices and strong earnings, though concentration in a few large stocks and sensitivity to Middle East tensions present volatility. Analyst sentiment is mixed with some calling the entry point less attractive after the rally, while others see continued upside potential from supply disruptions and AI infrastructure demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About Energy Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →
